Ischemic stroke in a man with hypertension, diabetes and smoking. Clinical case [ACV Isquémico en hombre con hipertensión, diabetes y tabaquismo. Caso clínico]
DOI:
https://doi.org/10.62574/wn1ned07Keywords:
brain edema, brain injuries, cerebrovascular disordersAbstract
Objective: To study ischemic stroke in men with hypertension, diabetes and smoking from a clinical case. Results and Conclusion: A 64-year-old unemployed man with a history of high blood pressure and diabetes, who has been actively smoking 10 cigarettes a day. The use of acute therapies, such as nimodipine and acetylsalicylic acid, together with secondary prevention strategies, are essential to improve prognosis and reduce the likelihood of recurrence.
Downloads
References
Putaala J. Ischemic Stroke in Young Adults. Continuum (Minneap Minn). 2020;26(2):386-414. doi:10.1212/CON.0000000000000833
Zhu H, Hu S, Li Y, et al. Interleukins and Ischemic Stroke. Front Immunol. 2022;13:828447. Published 2022 Jan 31. doi:10.3389/fimmu.2022.828447
Feske SK. Ischemic Stroke. Am J Med. 2021;134(12):1457-1464. doi:10.1016/j.amjmed.2021.07.027
Herpich F, Rincon F. Management of Acute Ischemic Stroke. Crit Care Med. 2020;48(11):1654-1663. doi:10.1097/CCM.0000000000004597
Walter K. What Is Acute Ischemic Stroke?. JAMA. 2022;327(9):885. doi:10.1001/jama.2022.1420
Jolugbo P, Ariëns RAS. Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke. Stroke. 2021;52(3):1131-1142. doi:10.1161/STROKEAHA.120.032810
Ajoolabady A, Wang S, Kroemer G, et al. Targeting autophagy in ischemic stroke: From molecular mechanisms to clinical therapeutics. Pharmacol Ther. 2021;225:107848. doi:10.1016/j.pharmthera.2021.107848
Zheng K, Lin L, Jiang W, et al. Single-cell RNA-seq reveals the transcriptional landscape in ischemic stroke. J Cereb Blood Flow Metab. 2022;42(1):56-73. doi:10.1177/0271678X211026770
Yoshimura S, Sakai N, Yamagami H, et al. Endovascular Therapy for Acute Stroke with a Large Ischemic Region. N Engl J Med. 2022;386(14):1303-1313. doi:10.1056/NEJMoa2118191
Shi Y, Guo L, Chen Y, et al. Risk factors for ischemic stroke: differences between cerebral small vessel and large artery atherosclerosis aetiologies. Folia Neuropathol. 2021;59(4):378-385. doi:10.5114/fn.2021.112007
Huo X, Ma G, Tong X, et al. Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct. N Engl J Med. 2023;388(14):1272-1283. doi:10.1056/NEJMoa2213379
Gao Y, Chen W, Pan Y, et al. Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke. N Engl J Med. 2023;389(26):2413-2424. doi:10.1056/NEJMoa2309137
Liu Y, Yu Y, Ouyang J, et al. Functional Outcome Prediction in Acute Ischemic Stroke Using a Fused Imaging and Clinical Deep Learning Model. Stroke. 2023;54(9):2316-2327. doi:10.1161/STROKEAHA.123.044072
Zhao W, Li S, Li C, et al. Effects of Tirofiban on Neurological Deterioration in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial [published correction appears in JAMA Neurol. 2024 Aug 1;81(8):889. doi: 10.1001/jamaneurol.2024.2195.]. JAMA Neurol. 2024;81(6):594-602. doi:10.1001/jamaneurol.2024.0868
Albers GW, Jumaa M, Purdon B, et al. Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection. N Engl J Med. 2024;390(8):701-711. doi:10.1056/NEJMoa2310392
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Copyright (c) 2024 By the authors. This article is open access and distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) licence (https://creativecommons.org/licenses/by-nc-sa/4.0/).
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
